1 Min Read
Feb 13 (Reuters) - VistaGen Therapeutics Inc
* VistaGen Therapeutics reports fiscal third quarter 2017 financial results and provides corporate update
* Q3 loss per share $0.34 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.